Unknown

Dataset Information

Transcriptome-Guided Drug Repurposing for Aggressive SCCs.


ABSTRACT: Despite a significant rise in the incidence of cutaneous squamous cell carcinoma (SCC) in recent years, most SCCs are well treatable. However, against the background of pre-existing risk factors such as immunosuppression upon organ transplantation, or conditions such as recessive dystrophic epidermolysis bullosa (RDEB), SCCs arise more frequently and follow a particularly aggressive course. Notably, such SCC types display molecular similarities, despite their differing etiologies. We leveraged the similarities in transcriptomes between tumors from organ transplant recipients and RDEB-patients, augmented with data from more common head and neck (HN)-SCCs, to identify drugs that can be repurposed to treat these SCCs. The in silico approach used is based on the assumption that SCC-derived tra

SUBMITTER: Zauner R 

PROVIDER: S-EPMC8780441 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature